
Pubmed-entry ::= {
  pmid 28497745,
  medent {
    em std {
      year 2017,
      month 5,
      day 13,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Preventive efficacy of NexGard Spectra((R)) against Dipylidium
 caninum infection in dogs using a natural flea (Ctenocephalides felis)
 infestation model.",
        trans "Efficacite preventive de NexGard Spectra((R)) contre l
'infection par Dipylidium caninum chez les chiens, utilisant un modele d
'infestation naturelle par des puces (Ctenocephalides felis)."
      },
      authors {
        names std {
          {
            name ml "Beugnet F",
            affil str "Merial, 29 avenue Tony Garnier, 69007 Lyon, France."
          },
          {
            name ml "Meyer L",
            affil str "ClinVet International (Pty) Ltd, 9321 Universitas,
 South Africa."
          },
          {
            name ml "Fourie J",
            affil str "ClinVet International (Pty) Ltd, 9321 Universitas,
 South Africa."
          },
          {
            name ml "Larsen D",
            affil str "Merial, 29 avenue Tony Garnier, 69007 Lyon, France."
          }
        }
      },
      from journal {
        title {
          iso-jta "Parasite",
          ml-jta "Parasite",
          issn "1776-1042",
          name "Parasite (Paris, France)"
        },
        imp {
          date std {
            year 2017
          },
          volume "24",
          pages "16",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus received,
              date std {
                year 2017,
                month 1,
                day 26
              }
            },
            {
              pubstatus accepted,
              date std {
                year 2017,
                month 4,
                day 20
              }
            },
            {
              pubstatus other,
              date std {
                year 2017,
                month 5,
                day 13,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 5,
                day 13,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2018,
                month 4,
                day 24,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 28497745,
        doi "10.1051/parasite/2017017",
        pii "parasite170013",
        other {
          db "pmc",
          tag str "PMC5432962"
        },
        other {
          db "ELocationID doi",
          tag str "10.1051/parasite/2017017"
        }
      }
    },
    abstract "The efficacy of a monthly oral endectocide product, NexGard
 Spectra((R)) (Merial), a combination of afoxolaner and milbemycin oxime, was
 evaluated in a flea (Ctenocephalides felis) challenge model for the
 prevention of Dipylidium caninum tapeworm infection in dogs. The efficacy of
 treatment with NexGard Spectra((R)) was assessed in 10 dogs following weekly
 flea infestation with metacestode naturally infected fleas and compared with
 that in 10 untreated control dogs. The 100 fleas deposited weekly on each dog
 were not removed until Day 35, allowing enough time for their ingestion. The
 microscopical analysis of 30 fleas from the flea batches before each weekly
 challenge demonstrated that 10-33% of the fleas were infected by D. caninum
 cysticercoid larvae. The arithmetic mean flea count recorded was 47.7 for the
 10 untreated dogs and 0 for the 10 treated dogs at Day 35. Based on the daily
 collection of expelled D. caninum proglottids by dogs during the 70 days of
 the study, 70% (7/10) of the control dogs and 0% (0/10) of the treated dogs
 were infected with D. caninum (p < 0.0031). Through its efficacy against
 fleas, NexGard Spectra((R)) treatment provided indirect prevention of D.
 caninum infestation. No treatment-related adverse events were observed in
 dogs during this study.",
    mesh {
      {
        term "Administration, Oral"
      },
      {
        term "Animals"
      },
      {
        term "Anthelmintics",
        qual {
          {
            mp TRUE,
            subh "administration & dosage"
          },
          {
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "Cestoda",
        qual {
          {
            subh "drug effects"
          }
        }
      },
      {
        term "Cestode Infections",
        qual {
          {
            subh "prevention & control"
          },
          {
            subh "transmission"
          },
          {
            mp TRUE,
            subh "veterinary"
          }
        }
      },
      {
        term "Ctenocephalides",
        qual {
          {
            mp TRUE,
            subh "parasitology"
          }
        }
      },
      {
        term "Dog Diseases",
        qual {
          {
            subh "parasitology"
          },
          {
            mp TRUE,
            subh "prevention & control"
          },
          {
            subh "transmission"
          }
        }
      },
      {
        term "Dogs"
      },
      {
        term "Drug Combinations"
      },
      {
        term "Female"
      },
      {
        term "Flea Infestations",
        qual {
          {
            subh "parasitology"
          },
          {
            mp TRUE,
            subh "veterinary"
          }
        }
      },
      {
        term "Isoxazoles",
        qual {
          {
            subh "administration & dosage"
          },
          {
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "Macrolides",
        qual {
          {
            subh "administration & dosage"
          },
          {
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "Male"
      },
      {
        term "Naphthalenes",
        qual {
          {
            subh "administration & dosage"
          },
          {
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "Anthelmintics"
      },
      {
        type nameonly,
        name "Drug Combinations"
      },
      {
        type nameonly,
        name "Isoxazoles"
      },
      {
        type nameonly,
        name "Macrolides"
      },
      {
        type nameonly,
        name "Naphthalenes"
      },
      {
        type cas,
        cit "02L07H6D0U",
        name "afoxolaner"
      },
      {
        type cas,
        cit "0502PUN0GT",
        name "milbemycin oxime"
      }
    },
    pmid 28497745,
    pub-type {
      "Journal Article",
      "Randomized Controlled Trial"
    },
    status medline
  }
}


